Literature DB >> 17159676

The resuscitative fluid you choose may potentiate bleeding.

Kathleen Brummel-Ziedins1, Matthew F Whelihan, Eduards G Ziedins, Kenneth G Mann.   

Abstract

BACKGROUND: Trauma is the leading cause of death in the younger population in the United States, frequently from the development of hemorrhagic shock. Controversy exists over the type of volume resuscitation for restoring hemodynamic stability that should be used in hemorrhagic shock. Little is known about how various resuscitative paradigms affect the coagulation cascade, which is essential to controlling hemorrhagic shock.
METHODS: We studied the effect of various resuscitative formulas on blood coagulation using a new model of whole blood in a controlled setting with corn trypsin inhibitor and a 5-pM stimulus of tissue factor. We investigated thrombin generation, fibrin formation, and platelet activation with four diluents: 0.9% NaCl (NS), lactated Ringer's solution (LR), 6% hydroxyethyl starch (HES), and 3% NaCl (HS), each from 0% to 75% blood dilution. Thrombin generation was measured periodically during a time course of 20 minutes in its complex with antithrombin III. Platelet activation and fibrinopeptide A (FPA) release were monitored in serum at a 20-minute time point. Fibrin clots were collected and weighed.
RESULTS: The coagulation markers (thrombin generation, platelet activation, and FPA release) were significantly different by dilution (p < 0.001 in all) and diluent by dilution (p < 0.001 in all). Thrombin generation, platelet activation, and FPA release decreased the least with the diluents NS and LR. LR caused the least amount of variation in thrombin generation over the dilution course. HS produced the most dramatic change in all of the markers; no coagulation was seen between 30% to 75% dilution (p < 0.05). HES produced greater decreases in thrombin generation and FPA release than NS and LR. Fibrin clot mass decreased with a 10% to 20% dilution for NS and LR, whereas stable fibrin mass did not decrease with the diluents HES and HS at 10% to 20% dilutions. At >30% dilutions, HS produced no stable clots and HES dramatically decreased clot formation by 61% and maintained this level.
CONCLUSIONS: LR and NS had the least effect on thrombin generation, clot formation, and platelet activation at various concentrations compared with HES and HS. This observational data suggests that volume expanders such as HES and HS may be detrimental in treatment of hemorrhagic shock.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17159676     DOI: 10.1097/01.ta.0000235525.64176.01

Source DB:  PubMed          Journal:  J Trauma        ISSN: 0022-5282


  11 in total

1.  Thrombin generation and bleeding in haemophilia A.

Authors:  K E Brummel-Ziedins; M F Whelihan; M Gissel; K G Mann; G E Rivard
Journal:  Haemophilia       Date:  2009-06-26       Impact factor: 4.287

2.  Prehospital Resuscitation of Traumatic Hemorrhagic Shock with Hypertonic Solutions Worsens Hypocoagulation and Hyperfibrinolysis.

Authors:  Matthew J Delano; Sandro B Rizoli; Shawn G Rhind; Joseph Cuschieri; Wolfgang Junger; Andrew J Baker; Michael A Dubick; David B Hoyt; Eileen M Bulger
Journal:  Shock       Date:  2015-07       Impact factor: 3.454

3.  Comparison of hypertonic saline and mannitol on whole blood coagulation in vitro assessed by thromboelastometry.

Authors:  Teemu Luostarinen; Tomohisa Niiya; Alexey Schramko; Per Rosenberg; Tomi Niemi
Journal:  Neurocrit Care       Date:  2011-04       Impact factor: 3.210

Review 4.  Posttraumatic massive bleeding: a challenging multidisciplinary task.

Authors:  Marco Marietta; Paola Pedrazzi; Massimo Girardis; Stefano Busani; Giuseppe Torelli
Journal:  Intern Emerg Med       Date:  2010-05-20       Impact factor: 3.397

Review 5.  Empirical and theoretical phenotypic discrimination.

Authors:  K E Brummel-Ziedins; T Orfeo; F R Rosendaal; A Undas; G E Rivard; S Butenas; K G Mann
Journal:  J Thromb Haemost       Date:  2009-07       Impact factor: 5.824

6.  The treatment of traumatic shock: recent advances and unresolved questions.

Authors:  K Sisak; D Dewar; N Butcher; K King; J Evans; M Miller; O Yoshino; P Harrigan; C Bendinelli; Z J Balogh
Journal:  Eur J Trauma Emerg Surg       Date:  2011-09-02       Impact factor: 3.693

7.  STS/SCA/AmSECT/SABM Update to the Clinical Practice Guidelines on Patient Blood Management.

Authors:  Pierre Tibi; R Scott McClure; Jiapeng Huang; Robert A Baker; David Fitzgerald; C David Mazer; Marc Stone; Danny Chu; Alfred H Stammers; Tim Dickinson; Linda Shore-Lesserson; Victor Ferraris; Scott Firestone; Kalie Kissoon; Susan Moffatt-Bruce
Journal:  J Extra Corpor Technol       Date:  2021-06

8.  Comparison of fibrin-based clot elasticity parameters measured by free oscillation rheometry (ReoRox ®) versus thromboelastometry (ROTEM ®).

Authors:  Cristina Solomon; Herbert Schöchl; Marco Ranucci; Ulf Schött; Christoph J Schlimp
Journal:  Scand J Clin Lab Invest       Date:  2015-01-19       Impact factor: 1.713

9.  Volume replacement with Ringer-lactate is detrimental in severe hemorrhagic shock but protective in moderate hemorrhagic shock: studies in a rat model.

Authors:  Bjoern Hussmann; Sven Lendemans; Herbert de Groot; Ricarda Rohrig
Journal:  Crit Care       Date:  2014-01-06       Impact factor: 9.097

10.  Prehospital resuscitation with hypertonic saline-dextran modulates inflammatory, coagulation and endothelial activation marker profiles in severe traumatic brain injured patients.

Authors:  Shawn G Rhind; Naomi T Crnko; Andrew J Baker; Laurie J Morrison; Pang N Shek; Sandro Scarpelini; Sandro B Rizoli
Journal:  J Neuroinflammation       Date:  2010-01-18       Impact factor: 8.322

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.